Nasdaq Gives Beneficient 180 Days to Restore $35 Million Market Value Threshold
Key Facts
Beneficient said it had received a notice from Nasdaq’s Listing Qualifications Department regarding its failure to meet the minimum market value of listed securities, according to an Investing.com report published on November 12, 2026. The notice gives the company an initial compliance period of 180 calendar days, ending on May 4, 2027, to restore the market value requirement. The notice does not immediately halt trading; the company said its Class A common stock and warrants continue to trade on the Nasdaq Capital Market under the symbols BENF and BENFW. The action gives Beneficient a specific deadline to address the listing violation, without representing an immediate delisting decision. BENF shares closed at $0.6807 on November 11, compared with a close of $0.7039 in the previous session.
The company received the notice on November 5, after Nasdaq found that the value of its listed securities had remained below the minimum threshold for 30 consecutive business days, from September 24 to November 4, 2026. The threshold the company failed to meet is $35 million under Listing Rule 5550(b)(2). The violation concerns the value of listed securities, a continued-listing requirement under the rule cited in the report. The notice also said Beneficient does not meet two alternative continued-listing standards related to minimum stockholders’ equity and net income from continuing operations. The notice therefore covers more than one compliance path, while Nasdaq’s granted period focuses on restoring the market value requirement.
To restore compliance, the company must have a market value of $35 million or more at the close for at least 10 consecutive business days before the deadline. Nasdaq retains the option to require a longer period to verify compliance, which is typically no more than 20 consecutive business days. If Beneficient does not regain compliance before May 4, 2027, Nasdaq will notify it that its securities are subject to delisting. The company would then have the right to appeal the decision to Nasdaq’s Hearings Panel. Beneficient said it is “monitoring its market value and evaluating options to regain compliance,” adding that “there can be no assurance” it will do so within the specified period.
The compliance period follows shareholder approval at a special meeting held on October 29 to issue Class A shares to Yorkville under an amended stock purchase agreement. Shares present or represented by proxy accounted for about 74.0% of the company’s total voting power, and the approval included an issuance that could exceed 20% of outstanding common shares. This remains separate from the Nasdaq notice, but is among the actions approved by the company in the period before the notice. Beneficient disclosed in its quarterly report substantial doubt about its ability to continue as a going concern, and said unrestricted cash was $5.6 million on June 30, 2026. It also reported a net loss of $164.7 million for the fiscal year ended March 31, 2026, with an accumulated deficit of $2.1 billion on that date.
Data for the quarter ended June 30, 2026, showed an improvement in operating income at Ben Liquidity, which recorded $7.354 million after posting an operating loss of $6.015 million in the same period of 2025. Regaining the listing requirement, however, requires the specified market value at the close for consecutive business days, under the criteria cited in the Investing.com report. Continued trading during the compliance period means the notice did not immediately change the company’s listing status, while the May 4, 2027, deadline remains the next decision point in the regulatory process. The company said it is evaluating options to regain compliance, without assurance that it will succeed. If the requirement is not met, the stated procedures provide for notice that the securities are subject to delisting, followed by an opportunity to appeal to the Nasdaq panel.